Enzymatic Synthesis of Heparin
Author:
Liu Renpeng,Liu Jian
Publisher
Springer Netherlands
Reference60 articles.
1. Howell, W. H., and Holt, E. (1918) Two new factors in blood coagulation-heparin and pro-antithrombin. Am J Physiol 47, 328–41. 2. Slaughter, T. F., and Greenberg, C. S. (1997) Heparin-associated thrombocytopenia and thrombosis: implications for perioperative management. Anesthesiology 83, 667–75. 3. Kishimoto, T. K., Viswanathan, K., Ganguly, T., Elankumaran, S., Smith, S., Pelzer, K., Lansing, J. C., Sriranganathan, N., Zhao, G., Galcheva-Gargova, Z., Al-Hakim, A., Bailey, G. S., Fraser, B., Roy, S., Rogers-Cotrone, T., Buhse, L., Whary, M., Fox, J., Nasr, M., Dal Pan, G. J., Shriver, Z., Langer, R. S., Venkataraman, G., Austen, K. F., Woodcock, J., and Sasisekharan, R. (2008) Contaminated heparin associated with adverse clinical events and activation of the contact system. N Engl J Med 358, 2457–67. 4. Guerrini, M., Beccati, D., Shriver, Z., Naggi, A., Viswanathan, K., Bisio, A., Capila, I., Lansing, J. C., Guglieri, S., Fraser, B., Al-Hakim, A., Gunay, N. S., Zhang, Z., Robinson, L., Buhse, L., Nasr, M., Woodcock, J., Langer, R., Venkataraman, G., Linhardt, R. J., Casu, B., Torri, G., and Sasisekharan, R. (2008) Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events. Nat Biotechnol 26, 669–75. 5. Zhang, Z., Weïwer, M., Li, B., Kemp, M. M., Daman, T. H., and Linhardt, R. J. (2008) Oversulfated chondroitin sulfate: impact of a heparin impurity, associated with adverse clinical events, on low-molecular-weight heparin preparation. J Med Chem 51, 5498–501.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|